Other languages Bone Biologics Corporation

Equities

BBLG

US0980705018

Market Closed - Nasdaq Other stock markets 03:59:51 2024-06-07 pm EDT			5-day change	1st Jan Change
1.54 ^USD	0.00%		-7.23%	-65.93%

May. 14	Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 04	Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	Mar. 01
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21
Bone Biologics Corporation Announces Board Changes	Jan. 11
Bone Biologics Corporation Announces the Resignation of Erick Lucera as Director	Jan. 02
Bone Biologics' 1-for-8 Reverse Stock Split Takes Effect Wednesday	Dec. 18
Bone Biologics Closes Common Stock Offering; Shares Fall After Hours	Nov. 20
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Top Midday Decliners	23-06-15
Top Premarket Decliners	23-06-15
Bone Biologics Prices Underwritten Public Offering of Common Stock	23-06-15
Bone Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Bone Biologics Corporation Auditor Raises 'Going Concern' Doubt	23-03-29
Top Premarket Decliners	23-03-22
Bone Biologics Corporation Resigns Stephen Laneve as Director	22-12-21
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Bone Biologics Prices $5.1 Million Securities Offering; Shares Plunge	22-10-07
Bone Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bone Biologics Corporation

Equities

BBLG

US0980705018

Other languages

Filters